Alexandra Galbo PHARMD

Recommended Articles

• 1 Week Pregnant

  IntroductionWomen who are not planning a pregnancy may not realize they are pregnant on week one. Some may not even know it even after week two. The reason is that there are a lot of variables when it comes to women’s monthly cycles, so most women tend to assume that they only have a late...

• Is Blue Apron Healthy?

  What is Blue Apron?When you think about food, perhaps you feel like there’s no big philosophy involved. In the past, the process was rather simple: you decide what would you want to eat, visit the market, buy the necessary ingredients, and prepare a meal. The food was usually grown locally, and in...

• What to Expect After Knee Replacement Surgery

  The major thing you would expect after a knee replacement is proper recovery and the successful outcome of the procedure. Knee replacement surgery is a procedure that is aimed at correcting a damaged knee joint. The recovery period after this operation varies depending on the type of surgery carried...

• 319 Pill

  319 PillThis pill is round in shape and white in color, and has an imprint of number “319”. It has been identified as tramadol hydrochloride 50 mg. It is used to treat restless legs syndrome (RLS), back pain, chronic pain, and fibromyalgia. It is supplied by Zydus Pharmaceuticals and belongs to...

• Breathlessness: Causes, Symptoms, and Treatment

  Introduction An unpleasant sensation of rapid breathing or difficulty breathing is known as breathlessness. People sometimes complain of feeling winded, puffed, or out of breath. Medically, it is called as dyspnea. Breathing may hurt and the person may feel tightness in the chest. It is normal to...

• What is the Melanoma Research Foundation?

  Melanoma Research Foundation (MRF) is a charitable institution devoted to melanoma treatment, research, and prevention. It was founded in 1996 by Diana Ashby, who also happened to suffer from recurrent melanoma. Despite her dying within 8 months after founding the MRF, the foundation continued to...